speb/financial-data huggingface dataset:
FRSX balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 76000.00
FRSX balance_sheet (quarterly, 2024-12-31) — Current Accrued Expenses: 76000.00
FRSX balance_sheet (annual, 2024-12-31) — Current Assets: 7846000.00
FRSX balance_sheet (quarterly, 2024-12-31) — Current Assets: 7846000.00
FRSX balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 289000.00
FRSX balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 289000.00
FRSX balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 289000.00
FRSX balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 289000.00
FRSX balance_sheet (annual, 2024-12-31) — Current Liabilities: 1743000.00
FRSX balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 1743000.00
FRSX cash_flow (annual, 2024-12-31) — Depreciation: 200000.00
FRSX cash_flow (quarterly, 2024-12-31) — Depreciation: 47000.00
FRSX cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 200000.00
FRSX cash_flow (quarterly, 2024-12-31) — Depreciation Amortization Depletion: 47000.00
FRSX cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 200000.00
FRSX cash_flow (quarterly, 2024-12-31) — Depreciation And Amortization: 47000.00
FRSX income_statement (annual, 2024-12-31) — Diluted Average Shares: 807477.00
FRSX income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 807477.00
FRSX income_statement (annual, 2024-12-31) — Diluted EPS: -13.79
FRSX income_statement (quarterly, 2024-12-31) — Diluted EPS: -3.84
FRSX income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -11138000.00
FRSX income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: -3100000.00
FRSX income_statement (annual, 2024-12-31) — EBIT: -12676000.00
FRSX income_statement (quarterly, 2024-12-31) — EBIT: -3175000.00
FRSX income_statement (annual, 2024-12-31) — EBITDA: -12476000.00
FRSX income_statement (quarterly, 2024-12-31) — EBITDA: -3128000.00
FRSX cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: -185000.00
FRSX cash_flow (quarterly, 2024-12-31) — Effect Of Exchange Rate Changes: 13000.00
FRSX cash_flow (annual, 2024-12-31) — End Cash Position: 7182000.00
FRSX cash_flow (quarterly, 2024-12-31) — End Cash Position: 7182000.00
FRSX cash_flow (annual, 2024-12-31) — Financing Cash Flow: 903000.00
FRSX cash_flow (quarterly, 2024-12-31) — Financing Cash Flow: 858000.00
FRSX cash_flow (annual, 2024-12-31) — Free Cash Flow: -11117000.00
FRSX cash_flow (quarterly, 2024-12-31) — Free Cash Flow: -2627000.00
FRSX income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 1116000.00
FRSX income_statement (annual, 2024-12-31) — General And Administrative Expense: 3632000.00
FRSX income_statement (quarterly, 2024-12-31) — General And Administrative Expense: 1725000.00
FRSX balance_sheet (annual, 2024-12-31) — Gross PPE: 3409000.00
FRSX balance_sheet (quarterly, 2024-12-31) — Gross PPE: 3409000.00
FRSX income_statement (annual, 2024-12-31) — Gross Profit: 264000.00
FRSX income_statement (quarterly, 2024-12-31) — Gross Profit: 77000.00
FRSX income_statement (annual, 2024-12-31) — Interest Income: 431000.00
FRSX income_statement (quarterly, 2024-12-31) — Interest Income: -1032000.00
FRSX income_statement (annual, 2024-12-31) — Interest Income Non Operating: 431000.00
FRSX income_statement (quarterly, 2024-12-31) — Interest Income Non Operating: -1032000.00
FRSX balance_sheet (annual, 2024-12-31) — Invested Capital: 6066000.00
FRSX balance_sheet (quarterly, 2024-12-31) — Invested Capital: 6066000.00
FRSX cash_flow (annual, 2024-12-31) — Investing Cash Flow: 1785000.00
FRSX cash_flow (quarterly, 2024-12-31) — Investing Cash Flow: -7000.00
FRSX cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 903000.00
FRSX cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 858000.00
FRSX balance_sheet (annual, 2024-12-31) — Leases: 502000.00
FRSX balance_sheet (quarterly, 2024-12-31) — Leases: 502000.00
FRSX balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 1272000.00
FRSX balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 1272000.00
FRSX balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 1272000.00
FRSX balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 1272000.00
FRSX balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 1331000.00
FRSX balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 1331000.00
FRSX balance_sheet (annual, 2024-12-31) — Minority Interest: 664000.00
FRSX balance_sheet (quarterly, 2024-12-31) — Minority Interest: 664000.00
FRSX cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 903000.00
FRSX cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 858000.00
FRSX cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: 185000.00
FRSX cash_flow (quarterly, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: -13000.00
FRSX income_statement (annual, 2024-12-31) — Net Income: -11138000.00
FRSX income_statement (quarterly, 2024-12-31) — Net Income: -3100000.00
FRSX income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -11138000.00
FRSX income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: -3100000.00
FRSX income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -11138000.00
FRSX income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: -3100000.00
FRSX income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -11138000.00
FRSX income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -3100000.00
FRSX income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -11138000.00
FRSX income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -3100000.00
FRSX cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -11138000.00
FRSX cash_flow (quarterly, 2024-12-31) — Net Income From Continuing Operations: -3100000.00
FRSX income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -11138000.00
FRSX income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: -3100000.00
FRSX income_statement (annual, 2024-12-31) — Net Interest Income: 422000.00
FRSX income_statement (quarterly, 2024-12-31) — Net Interest Income: -1041000.00
FRSX cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 1847000.00
FRSX cash_flow (quarterly, 2024-12-31) — Net Investment Purchase And Sale: 0.00
FRSX income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 422000.00
FRSX income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -1041000.00
FRSX balance_sheet (annual, 2024-12-31) — Net PPE: 1899000.00
FRSX balance_sheet (quarterly, 2024-12-31) — Net PPE: 1899000.00
FRSX cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -62000.00
FRSX cash_flow (quarterly, 2024-12-31) — Net PPE Purchase And Sale: -7000.00
FRSX balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 6066000.00
FRSX balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 6066000.00
FRSX income_statement (annual, 2024-12-31) — Normalized EBITDA: -13592000.00
FRSX income_statement (quarterly, 2024-12-31) — Normalized EBITDA: -3128000.00
FRSX income_statement (annual, 2024-12-31) — Normalized Income: -12254000.00
FRSX income_statement (quarterly, 2024-12-31) — Normalized Income: -3100000.00
FRSX cash_flow (annual, 2024-12-31) — Operating Cash Flow: -11055000.00
FRSX cash_flow (quarterly, 2024-12-31) — Operating Cash Flow: -2620000.00
FRSX cash_flow (annual, 2024-12-31) — Operating Gains Losses: 185000.00
FRSX cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: -13000.00
FRSX income_statement (annual, 2024-12-31) — Operating Income: -12676000.00
FRSX income_statement (quarterly, 2024-12-31) — Operating Income: -3175000.00
FRSX income_statement (annual, 2024-12-31) — Operating Revenue: 436000.00
FRSX income_statement (quarterly, 2024-12-31) — Operating Revenue: 101000.00
FRSX balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 72672956.00
FRSX balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 72672956.00
FRSX income_statement (annual, 2024-12-31) — Other Gand A: 1195000.00
FRSX income_statement (quarterly, 2024-12-31) — Other Gand A: -712000.00
FRSX income_statement (annual, 2024-12-31) — Other Income Expense: 1116000.00
FRSX balance_sheet (annual, 2024-12-31) — Other Payable: 83000.00
FRSX balance_sheet (quarterly, 2024-12-31) — Other Payable: 83000.00
FRSX balance_sheet (annual, 2024-12-31) — Other Properties: 1576000.00
FRSX balance_sheet (quarterly, 2024-12-31) — Other Properties: 1576000.00
FRSX balance_sheet (annual, 2024-12-31) — Other Receivables: 248000.00
FRSX balance_sheet (quarterly, 2024-12-31) — Other Receivables: 248000.00
FRSX balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 71000.00
FRSX balance_sheet (quarterly, 2024-12-31) — Other Short Term Investments: 71000.00
FRSX balance_sheet (annual, 2024-12-31) — Payables: 380000.00
FRSX balance_sheet (quarterly, 2024-12-31) — Payables: 380000.00
FRSX balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 456000.00
FRSX balance_sheet (quarterly, 2024-12-31) — Payables And Accrued Expenses: 456000.00
FRSX balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 998000.00
FRSX balance_sheet (quarterly, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 998000.00
FRSX balance_sheet (annual, 2024-12-31) — Prepaid Assets: 232000.00
FRSX balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 232000.00
FRSX income_statement (annual, 2024-12-31) — Pretax Income: -11138000.00
FRSX income_statement (quarterly, 2024-12-31) — Pretax Income: -3100000.00
FRSX balance_sheet (annual, 2024-12-31) — Properties: 0.00
FRSX balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
FRSX cash_flow (annual, 2024-12-31) — Purchase Of Investment: 0.00
FRSX cash_flow (annual, 2024-12-31) — Purchase Of PPE: -62000.00
FRSX cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: -7000.00
FRSX balance_sheet (annual, 2024-12-31) — Receivables: 361000.00
FRSX balance_sheet (quarterly, 2024-12-31) — Receivables: 361000.00
FRSX income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 172000.00
FRSX income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 24000.00
FRSX income_statement (annual, 2024-12-31) — Reconciled Depreciation: 200000.00
FRSX income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 47000.00
FRSX income_statement (annual, 2024-12-31) — Rent And Landing Fees: 283000.00
FRSX income_statement (annual, 2024-12-31) — Rent Expense Supplemental: 283000.00
FRSX income_statement (annual, 2024-12-31) — Research And Development: 9143000.00
FRSX income_statement (quarterly, 2024-12-31) — Research And Development: 2176000.00
FRSX balance_sheet (annual, 2024-12-31) — Restricted Cash: 100000.00
FRSX balance_sheet (quarterly, 2024-12-31) — Restricted Cash: 100000.00
FRSX balance_sheet (annual, 2024-12-31) — Retained Earnings: -131028000.00
FRSX balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -131028000.00
FRSX income_statement (annual, 2024-12-31) — Salaries And Wages: 2154000.00
FRSX cash_flow (annual, 2024-12-31) — Sale Of Investment: 1847000.00
FRSX cash_flow (quarterly, 2024-12-31) — Sale Of Investment: 0.00
FRSX income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 165000.00
FRSX income_statement (quarterly, 2024-12-31) — Selling And Marketing Expense: -649000.00
FRSX income_statement (annual, 2024-12-31) — Selling General And Administration: 3797000.00
FRSX income_statement (quarterly, 2024-12-31) — Selling General And Administration: 1076000.00
FRSX balance_sheet (annual, 2024-12-31) — Share Issued: 72672956.00
FRSX balance_sheet (quarterly, 2024-12-31) — Share Issued: 72672956.00
FRSX cash_flow (annual, 2024-12-31) — Stock Based Compensation: 788000.00
FRSX cash_flow (quarterly, 2024-12-31) — Stock Based Compensation: 253000.00
FRSX balance_sheet (annual, 2024-12-31) — Stockholders Equity: 6066000.00
FRSX balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 6066000.00
FRSX balance_sheet (annual, 2024-12-31) — Tangible Book Value: 6066000.00
FRSX balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 6066000.00
FRSX income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
FRSX income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
FRSX income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
FRSX income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.00
FRSX balance_sheet (annual, 2024-12-31) — Total Assets: 9745000.00
FRSX balance_sheet (quarterly, 2024-12-31) — Total Assets: 9745000.00
FRSX balance_sheet (annual, 2024-12-31) — Total Capitalization: 6066000.00
FRSX balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 6066000.00
FRSX balance_sheet (annual, 2024-12-31) — Total Debt: 1561000.00
FRSX balance_sheet (quarterly, 2024-12-31) — Total Debt: 1561000.00
FRSX balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 6730000.00
FRSX balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 6730000.00
FRSX income_statement (annual, 2024-12-31) — Total Expenses: 13112000.00
FRSX income_statement (quarterly, 2024-12-31) — Total Expenses: 3276000.00
FRSX balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 3015000.00
FRSX balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 3015000.00
FRSX balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 1899000.00
FRSX balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 1899000.00
FRSX balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 1272000.00
FRSX balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 1272000.00
FRSX income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -12676000.00
FRSX income_statement (quarterly, 2024-12-31) — Total Operating Income As Reported: -3175000.00
FRSX income_statement (annual, 2024-12-31) — Total Other Finance Cost: 9000.00
FRSX income_statement (annual, 2024-12-31) — Total Unusual Items: 1116000.00
FRSX income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 1116000.00
FRSX cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: -1444000.00
FRSX cash_flow (quarterly, 2024-12-31) — Unrealized Gain Loss On Investment Securities: -56000.00
FRSX balance_sheet (annual, 2024-12-31) — Working Capital: 6103000.00
FRSX balance_sheet (quarterly, 2024-12-31) — Working Capital: 6103000.00
FRSX income_statement (quarterly, 2025-06-30) — +Operating Expense: 3037000.00
FRSX income_statement (quarterly, 2025-06-30) — +Total Revenue: 128000.00
FRSX balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 154000.00
FRSX balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 33000.00
FRSX balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 142984000.00
FRSX income_statement (quarterly, 2025-06-30) — Basic Average Shares: 1130481.00
FRSX income_statement (quarterly, 2025-06-30) — Basic EPS: -2.44
FRSX cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 8849000.00
FRSX cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -3000.00
FRSX balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 1562000.00
FRSX balance_sheet (quarterly, 2025-06-30) — Capital Stock: 0.00
FRSX balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 6342000.00
FRSX balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 6367000.00
FRSX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 0.00
FRSX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -3000.00
FRSX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -2610000.00
FRSX cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -250000.00
FRSX cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: 146000.00
FRSX cash_flow (quarterly, 2025-06-30) — Change In Payable: -260000.00
FRSX cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -260000.00
FRSX cash_flow (quarterly, 2025-06-30) — Change In Receivables: 227000.00
FRSX cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 113000.00
FRSX cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 99000.00
FRSX cash_flow (quarterly, 2025-06-30) — Changes In Cash: -2613000.00
FRSX balance_sheet (quarterly, 2025-06-30) — Common Stock: 0.00
FRSX balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 5931000.00
FRSX cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 0.00
FRSX income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 42000.00
FRSX balance_sheet (quarterly, 2025-06-30) — Current Assets: 6881000.00
FRSX balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 348000.00
FRSX balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 348000.00
FRSX balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 1710000.00
FRSX cash_flow (quarterly, 2025-06-30) — Depreciation: 26000.00
FRSX cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 26000.00
FRSX cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 26000.00
FRSX income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 1130481.00
FRSX income_statement (quarterly, 2025-06-30) — Diluted EPS: -2.44
FRSX income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -2759000.00
FRSX income_statement (quarterly, 2025-06-30) — EBIT: -2951000.00
FRSX income_statement (quarterly, 2025-06-30) — EBITDA: -2925000.00
FRSX cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 156000.00
FRSX cash_flow (quarterly, 2025-06-30) — End Cash Position: 6392000.00
FRSX cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 0.00
FRSX cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -2613000.00
FRSX income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 586000.00
FRSX balance_sheet (quarterly, 2025-06-30) — Gross PPE: 1668000.00
FRSX income_statement (quarterly, 2025-06-30) — Gross Profit: 86000.00
FRSX balance_sheet (quarterly, 2025-06-30) — Invested Capital: 5931000.00
FRSX cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -3000.00
FRSX cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 0.00
FRSX balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 1214000.00
FRSX balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 1214000.00
FRSX balance_sheet (quarterly, 2025-06-30) — Minority Interest: -306000.00
FRSX income_statement (quarterly, 2025-06-30) — Minority Interests: 56000.00
FRSX cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
FRSX cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: -156000.00
FRSX income_statement (quarterly, 2025-06-30) — Net Income: -2759000.00
FRSX income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -2759000.00
FRSX income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -2815000.00
FRSX income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -2759000.00
FRSX income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -2759000.00
FRSX cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -2815000.00
FRSX income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -2815000.00
FRSX income_statement (quarterly, 2025-06-30) — Net Interest Income: 136000.00
FRSX cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 0.00
FRSX income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 136000.00
FRSX balance_sheet (quarterly, 2025-06-30) — Net PPE: 1668000.00
FRSX cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -3000.00
FRSX balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 5931000.00
FRSX income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -2925000.00
FRSX income_statement (quarterly, 2025-06-30) — Normalized Income: -2759000.00
FRSX cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -2610000.00
FRSX cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -156000.00
FRSX income_statement (quarterly, 2025-06-30) — Operating Income: -2951000.00
FRSX income_statement (quarterly, 2025-06-30) — Operating Revenue: 128000.00
FRSX balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 101743325.00
FRSX income_statement (quarterly, 2025-06-30) — Other Gand A: 586000.00
FRSX balance_sheet (quarterly, 2025-06-30) — Other Payable: 1208000.00
FRSX balance_sheet (quarterly, 2025-06-30) — Other Properties: 1668000.00
FRSX balance_sheet (quarterly, 2025-06-30) — Other Receivables: 431000.00
FRSX balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 25000.00
FRSX balance_sheet (quarterly, 2025-06-30) — Payables: 1362000.00
FRSX balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 1362000.00
FRSX income_statement (quarterly, 2025-06-30) — Pretax Income: -2815000.00
FRSX cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -3000.00
FRSX balance_sheet (quarterly, 2025-06-30) — Receivables: 464000.00
FRSX income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 42000.00
FRSX income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 26000.00
FRSX income_statement (quarterly, 2025-06-30) — Research And Development: 2156000.00
FRSX balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 50000.00
FRSX balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -137053000.00
FRSX cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 0.00
FRSX income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 295000.00
FRSX income_statement (quarterly, 2025-06-30) — Selling General And Administration: 881000.00
FRSX balance_sheet (quarterly, 2025-06-30) — Share Issued: 101743325.00
FRSX cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 217000.00
FRSX balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 5931000.00
FRSX balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 5931000.00
FRSX income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
FRSX income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
FRSX balance_sheet (quarterly, 2025-06-30) — Total Assets: 8549000.00
FRSX balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 5931000.00
FRSX balance_sheet (quarterly, 2025-06-30) — Total Debt: 1562000.00
FRSX balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 5625000.00
FRSX income_statement (quarterly, 2025-06-30) — Total Expenses: 3079000.00
FRSX balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 2924000.00
FRSX balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 1668000.00
FRSX balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 1214000.00
FRSX income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -2951000.00
FRSX income_statement (quarterly, 2025-06-30) — Total Other Finance Cost: -136000.00
FRSX cash_flow (quarterly, 2025-06-30) — Unrealized Gain Loss On Investment Securities: 5000.00
FRSX balance_sheet (quarterly, 2025-06-30) — Working Capital: 5171000.00
FRSX income_statement (annual, 2025-12-31) — +Operating Expense: 12439000.00
FRSX income_statement (annual, 2025-12-31) — +Total Revenue: 398000.00
FRSX balance_sheet (annual, 2025-12-31) — Accounts Payable: 249000.00
FRSX balance_sheet (annual, 2025-12-31) — Accounts Receivable: 118000.00
FRSX balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -1550000.00
FRSX balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 149164000.00
FRSX income_statement (annual, 2025-12-31) — Basic Average Shares: 1562605.00
FRSX income_statement (quarterly, 2025-12-31) — Basic Average Shares: 1562605.00
FRSX income_statement (annual, 2025-12-31) — Basic EPS: -7.75
FRSX income_statement (quarterly, 2025-12-31) — Basic EPS: -1.86
FRSX cash_flow (annual, 2025-12-31) — Beginning Cash Position: 7182000.00
FRSX cash_flow (annual, 2025-12-31) — Capital Expenditure: -25000.00
FRSX balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 1512000.00
FRSX balance_sheet (annual, 2025-12-31) — Capital Stock: 0.00
FRSX balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 6236000.00
FRSX balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 6262000.00
FRSX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 9476000.00
FRSX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -25000.00
FRSX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -10453000.00
FRSX cash_flow (annual, 2025-12-31) — Change In Account Payable: -48000.00
FRSX cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 82000.00
FRSX cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 192000.00
FRSX cash_flow (annual, 2025-12-31) — Change In Payable: 337000.00
FRSX cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 337000.00
FRSX cash_flow (annual, 2025-12-31) — Change In Receivables: -5000.00
FRSX cash_flow (annual, 2025-12-31) — Change In Working Capital: 606000.00
FRSX cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -5000.00
FRSX cash_flow (annual, 2025-12-31) — Changes In Cash: -1002000.00
FRSX balance_sheet (annual, 2025-12-31) — Common Stock: 0.00
FRSX balance_sheet (annual, 2025-12-31) — Common Stock Equity: 6233000.00
FRSX cash_flow (annual, 2025-12-31) — Common Stock Issuance: 9476000.00
FRSX income_statement (annual, 2025-12-31) — Cost Of Revenue: 140000.00
FRSX balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 277000.00
FRSX balance_sheet (annual, 2025-12-31) — Current Assets: 6831000.00
FRSX balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 339000.00
FRSX balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 339000.00
FRSX balance_sheet (annual, 2025-12-31) — Current Liabilities: 2069000.00
FRSX cash_flow (annual, 2025-12-31) — Depreciation: 161000.00
FRSX cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 161000.00
FRSX cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 161000.00
FRSX income_statement (annual, 2025-12-31) — Diluted Average Shares: 1562605.00
FRSX income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 1562605.00
FRSX income_statement (annual, 2025-12-31) — Diluted EPS: -7.75
FRSX income_statement (quarterly, 2025-12-31) — Diluted EPS: -1.86
FRSX income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -12103000.00
FRSX income_statement (annual, 2025-12-31) — EBIT: -12181000.00
FRSX income_statement (annual, 2025-12-31) — EBITDA: -12020000.00
FRSX cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 109000.00
FRSX cash_flow (annual, 2025-12-31) — End Cash Position: 6289000.00
FRSX cash_flow (annual, 2025-12-31) — Financing Cash Flow: 9476000.00
FRSX cash_flow (annual, 2025-12-31) — Free Cash Flow: -10478000.00
FRSX income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -67000.00
FRSX income_statement (annual, 2025-12-31) — General And Administrative Expense: 3664000.00
FRSX balance_sheet (annual, 2025-12-31) — Gross PPE: 3072000.00
FRSX income_statement (annual, 2025-12-31) — Gross Profit: 258000.00
FRSX income_statement (annual, 2025-12-31) — Interest Income: 155000.00
FRSX income_statement (annual, 2025-12-31) — Interest Income Non Operating: 155000.00
FRSX balance_sheet (annual, 2025-12-31) — Invested Capital: 6233000.00
FRSX cash_flow (annual, 2025-12-31) — Investing Cash Flow: -25000.00
FRSX cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 9476000.00
FRSX balance_sheet (annual, 2025-12-31) — Leases: 392000.00
FRSX balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 1173000.00
FRSX balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 1173000.00
FRSX balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 1345000.00
FRSX balance_sheet (annual, 2025-12-31) — Minority Interest: -1122000.00
FRSX cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 9476000.00
FRSX cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: -109000.00
FRSX income_statement (annual, 2025-12-31) — Net Income: -12103000.00
FRSX income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -12103000.00
FRSX income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -12103000.00
FRSX income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -12103000.00
FRSX income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -12103000.00
FRSX cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -12103000.00
FRSX income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -12103000.00
FRSX income_statement (annual, 2025-12-31) — Net Interest Income: 145000.00
FRSX cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 0.00
FRSX income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 145000.00
FRSX balance_sheet (annual, 2025-12-31) — Net PPE: 1522000.00
FRSX cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -25000.00
FRSX balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 6233000.00
FRSX income_statement (annual, 2025-12-31) — Normalized EBITDA: -11953000.00
FRSX income_statement (annual, 2025-12-31) — Normalized Income: -12036000.00
FRSX cash_flow (annual, 2025-12-31) — Operating Cash Flow: -10453000.00
FRSX cash_flow (annual, 2025-12-31) — Operating Gains Losses: -109000.00
FRSX income_statement (annual, 2025-12-31) — Operating Income: -12181000.00
FRSX income_statement (annual, 2025-12-31) — Operating Revenue: 398000.00
FRSX balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 140634421.00
FRSX income_statement (annual, 2025-12-31) — Other Gand A: 1177000.00
FRSX income_statement (annual, 2025-12-31) — Other Income Expense: -67000.00
FRSX balance_sheet (annual, 2025-12-31) — Other Payable: 231000.00
FRSX balance_sheet (annual, 2025-12-31) — Other Properties: 1335000.00
FRSX balance_sheet (annual, 2025-12-31) — Other Receivables: 252000.00
FRSX balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 26000.00
FRSX balance_sheet (annual, 2025-12-31) — Payables: 480000.00
FRSX balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 757000.00
FRSX balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 973000.00
FRSX balance_sheet (annual, 2025-12-31) — Prepaid Assets: 146000.00
FRSX income_statement (annual, 2025-12-31) — Pretax Income: -12103000.00
FRSX balance_sheet (annual, 2025-12-31) — Properties: 0.00
FRSX cash_flow (annual, 2025-12-31) — Purchase Of PPE: -25000.00
FRSX balance_sheet (annual, 2025-12-31) — Receivables: 370000.00
FRSX income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 140000.00
FRSX income_statement (annual, 2025-12-31) — Reconciled Depreciation: 161000.00
FRSX income_statement (annual, 2025-12-31) — Rent And Landing Fees: 266000.00
FRSX income_statement (annual, 2025-12-31) — Rent Expense Supplemental: 266000.00
FRSX income_statement (annual, 2025-12-31) — Research And Development: 8629000.00
FRSX balance_sheet (annual, 2025-12-31) — Restricted Cash: 53000.00
FRSX balance_sheet (annual, 2025-12-31) — Retained Earnings: -142931000.00
FRSX income_statement (annual, 2025-12-31) — Salaries And Wages: 2221000.00
FRSX cash_flow (annual, 2025-12-31) — Sale Of Investment: 0.00
FRSX income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 146000.00
FRSX income_statement (annual, 2025-12-31) — Selling General And Administration: 3810000.00
FRSX balance_sheet (annual, 2025-12-31) — Share Issued: 140634421.00
FRSX cash_flow (annual, 2025-12-31) — Stock Based Compensation: 947000.00
FRSX balance_sheet (annual, 2025-12-31) — Stockholders Equity: 6233000.00
FRSX balance_sheet (annual, 2025-12-31) — Tangible Book Value: 6233000.00
FRSX income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
FRSX income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
FRSX balance_sheet (annual, 2025-12-31) — Total Assets: 8353000.00
FRSX balance_sheet (annual, 2025-12-31) — Total Capitalization: 6233000.00
FRSX balance_sheet (annual, 2025-12-31) — Total Debt: 1512000.00
FRSX balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 5111000.00
FRSX income_statement (annual, 2025-12-31) — Total Expenses: 12579000.00
FRSX balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 3242000.00
FRSX balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 1522000.00
FRSX balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 1173000.00
FRSX income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -12181000.00
FRSX income_statement (annual, 2025-12-31) — Total Other Finance Cost: 10000.00
FRSX income_statement (annual, 2025-12-31) — Total Unusual Items: -67000.00
FRSX income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -67000.00
FRSX cash_flow (annual, 2025-12-31) — Unrealized Gain Loss On Investment Securities: 45000.00
FRSX balance_sheet (annual, 2025-12-31) — Working Capital: 4762000.00
FRT cash_flow (annual, 2021-12-31) — Change In Other Working Capital: 10712000.00
FRT cash_flow (annual, 2021-12-31) — Depreciation: 279976000.00
FRT cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of Business: 0.00
FRT income_statement (annual, 2021-12-31) — Gain On Sale Of Business: 0.00
FRT balance_sheet (annual, 2021-12-31) — Line Of Credit: 0.00
FRT balance_sheet (annual, 2021-12-31) — Other Current Assets: 237069000.00
FRT balance_sheet (annual, 2021-12-31) — Preferred Securities Outside Stock Equity: 213708000.00
FRT balance_sheet (annual, 2021-12-31) — Prepaid Assets: 237069000.00
FRT balance_sheet (annual, 2021-12-31) — Restricted Cash: 13031000.00
FRT income_statement (annual, 2022-12-31) — +Operating Expense: 355045000.00
FRT income_statement (annual, 2022-12-31) — +Total Revenue: 1074378000.00
FRT balance_sheet (annual, 2022-12-31) — Accounts Payable: 190340000.00
FRT balance_sheet (annual, 2022-12-31) — Accounts Receivable: 197648000.00
FRT balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 3821801000.00
FRT cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 0.00
FRT income_statement (annual, 2022-12-31) — Average Dilution Earnings: 2810000.00
FRT income_statement (annual, 2022-12-31) — Basic Average Shares: 79854000.00
FRT income_statement (annual, 2022-12-31) — Basic EPS: 4.71
FRT cash_flow (annual, 2022-12-31) — Beginning Cash Position: 175163000.00
FRT cash_flow (annual, 2022-12-31) — Capital Expenditure: -416701000.00
FRT cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -416701000.00
FRT balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 145403000.00
FRT balance_sheet (annual, 2022-12-31) — Capital Stock: 160640000.00
FRT balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 85558000.00
FRT balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 85558000.00
FRT cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -347284000.00
FRT cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 190414000.00
FRT cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -785998000.00
FRT cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 516769000.00
FRT cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 10373000.00
FRT cash_flow (annual, 2022-12-31) — Change In Other Working Capital: 10373000.00
FRT cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 77000.00
FRT cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -1219000.00
FRT cash_flow (annual, 2022-12-31) — Change In Receivables: -12071000.00
FRT cash_flow (annual, 2022-12-31) — Change In Working Capital: -2840000.00
FRT cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -12071000.00
FRT cash_flow (annual, 2022-12-31) — Changes In Cash: -78815000.00
FRT balance_sheet (annual, 2022-12-31) — Common Stock: 818000.00
FRT balance_sheet (annual, 2022-12-31) — Common Stock Equity: 2794190000.00
FRT cash_flow (annual, 2022-12-31) — Common Stock Issuance: 307275000.00
FRT cash_flow (annual, 2022-12-31) — Common Stock Payments: -4900000.00
FRT income_statement (annual, 2022-12-31) — Cost Of Revenue: 356782000.00
FRT balance_sheet (annual, 2022-12-31) — Current Assets: 292662000.00
FRT balance_sheet (annual, 2022-12-31) — Current Liabilities: 309111000.00
FRT cash_flow (annual, 2022-12-31) — Depreciation: 302409000.00
FRT cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 302409000.00
FRT income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 302409000.00
FRT cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 302409000.00
FRT income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 302409000.00
FRT income_statement (annual, 2022-12-31) — Diluted Average Shares: 80508000.00
FRT income_statement (annual, 2022-12-31) — Diluted EPS: 4.71
FRT income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 378939000.00
FRT balance_sheet (annual, 2022-12-31) — Dividends Payable: 90263000.00
FRT cash_flow (annual, 2022-12-31) — Dividends Received Cfi: 6864000.00
FRT income_statement (annual, 2022-12-31) — EBIT: 532650000.00
FRT income_statement (annual, 2022-12-31) — EBITDA: 835059000.00
FRT income_statement (annual, 2022-12-31) — Earnings From Equity Interest: 5170000.00
FRT cash_flow (annual, 2022-12-31) — Earnings Losses From Equity Investments: -5170000.00
FRT cash_flow (annual, 2022-12-31) — End Cash Position: 96348000.00
FRT cash_flow (annual, 2022-12-31) — Financing Cash Flow: 190414000.00
FRT cash_flow (annual, 2022-12-31) — Free Cash Flow: 100068000.00
FRT cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: -93483000.00
FRT cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: -70374000.00
FRT income_statement (annual, 2022-12-31) — Gain On Sale Of Business: 70374000.00
FRT income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 93483000.00
FRT balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: 5757000.00
FRT income_statement (annual, 2022-12-31) — General And Administrative Expense: 52636000.00
FRT balance_sheet (annual, 2022-12-31) — Gross PPE: 140036000.00
FRT income_statement (annual, 2022-12-31) — Gross Profit: 717596000.00
FRT income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 0.00
FRT cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 624000.00
FRT income_statement (annual, 2022-12-31) — Interest Expense: 136989000.00
FRT income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 136989000.00
FRT income_statement (annual, 2022-12-31) — Interest Income: 1072000.00
FRT income_statement (annual, 2022-12-31) — Interest Income Non Operating: 1072000.00
FRT cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 130912000.00
FRT balance_sheet (annual, 2022-12-31) — Invested Capital: 7123583000.00
FRT cash_flow (annual, 2022-12-31) — Investing Cash Flow: -785998000.00
FRT balance_sheet (annual, 2022-12-31) — Investment Properties: 7388682000.00
FRT balance_sheet (annual, 2022-12-31) — Investments And Advances: 145205000.00
FRT balance_sheet (annual, 2022-12-31) — Investments In Other Ventures Under Equity Method: 145205000.00
FRT cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 307275000.00
FRT cash_flow (annual, 2022-12-31) — Issuance Of Debt: 298568000.00
FRT balance_sheet (annual, 2022-12-31) — Line Of Credit: 0.00
FRT balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 145403000.00
FRT balance_sheet (annual, 2022-12-31) — Long Term Debt: 4329393000.00
FRT balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 4474796000.00
FRT cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 298568000.00
FRT cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -19443000.00
FRT balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 145205000.00
FRT balance_sheet (annual, 2022-12-31) — Minority Interest: 258373000.00
FRT income_statement (annual, 2022-12-31) — Minority Interests: -10170000.00
FRT cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -27347000.00
FRT cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 302375000.00
FRT balance_sheet (annual, 2022-12-31) — Net Debt: 4243835000.00
FRT income_statement (annual, 2022-12-31) — Net Income: 385491000.00
FRT income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 376129000.00
FRT income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 395661000.00
FRT income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 385491000.00
FRT income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 385491000.00
FRT cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 395661000.00
FRT income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 395661000.00
FRT income_statement (annual, 2022-12-31) — Net Interest Income: -135917000.00
FRT cash_flow (annual, 2022-12-31) — Net Investment Properties Purchase And Sale: -304777000.00
FRT cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 279125000.00
FRT cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 279125000.00
FRT income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -135917000.00
FRT cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -43802000.00
FRT cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -44037000.00
FRT balance_sheet (annual, 2022-12-31) — Net PPE: 140036000.00
FRT balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 2954012000.00
FRT income_statement (annual, 2022-12-31) — Normalized EBITDA: 671202000.00
FRT income_statement (annual, 2022-12-31) — Normalized Income: 256043970.00
FRT balance_sheet (annual, 2022-12-31) — Notes Receivable: 9456000.00
FRT cash_flow (annual, 2022-12-31) — Operating Cash Flow: 516769000.00
FRT cash_flow (annual, 2022-12-31) — Operating Gains Losses: -169027000.00
FRT income_statement (annual, 2022-12-31) — Operating Income: 362551000.00
FRT income_statement (annual, 2022-12-31) — Operating Revenue: 1048879000.00
FRT balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 81342959.00
FRT balance_sheet (annual, 2022-12-31) — Other Current Assets: 267406000.00
FRT balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: 5757000.00
FRT income_statement (annual, 2022-12-31) — Other Gand A: 52636000.00
FRT income_statement (annual, 2022-12-31) — Other Income Expense: 169027000.00
FRT cash_flow (annual, 2022-12-31) — Other Non Cash Items: -23138000.00
FRT balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 267406000.00
FRT balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 237699000.00
FRT balance_sheet (annual, 2022-12-31) — Other Payable: 28508000.00
FRT balance_sheet (annual, 2022-12-31) — Other Properties: 140036000.00
FRT income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 1328000.00
FRT balance_sheet (annual, 2022-12-31) — Payables: 309111000.00
FRT balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 309111000.00
FRT balance_sheet (annual, 2022-12-31) — Preferred Shares Number: 6000000.00
FRT balance_sheet (annual, 2022-12-31) — Preferred Stock: 159822000.00
FRT income_statement (annual, 2022-12-31) — Preferred Stock Dividends: 8034000.00
FRT balance_sheet (annual, 2022-12-31) — Preferred Stock Equity: 159822000.00
FRT income_statement (annual, 2022-12-31) — Pretax Income: 395661000.00
FRT cash_flow (annual, 2022-12-31) — Purchase Of Business: -27347000.00
FRT cash_flow (annual, 2022-12-31) — Purchase Of Investment Properties: -438494000.00
FRT balance_sheet (annual, 2022-12-31) — Receivables: 207104000.00
FRT income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 356782000.00
FRT income_statement (annual, 2022-12-31) — Reconciled Depreciation: 302409000.00
FRT income_statement (annual, 2022-12-31) — Rent Expense Supplemental: 228958000.00
FRT cash_flow (annual, 2022-12-31) — Repayment Of Debt: -19443000.00
FRT cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -4900000.00
FRT balance_sheet (annual, 2022-12-31) — Retained Earnings: -1034186000.00
FRT cash_flow (annual, 2022-12-31) — Sale Of Investment Properties: 133717000.00
FRT income_statement (annual, 2022-12-31) — Selling General And Administration: 52636000.00
FRT balance_sheet (annual, 2022-12-31) — Share Issued: 81342959.00
FRT income_statement (annual, 2022-12-31) — Special Income Charges: 70374000.00
FRT cash_flow (annual, 2022-12-31) — Stock Based Compensation: 13704000.00
FRT balance_sheet (annual, 2022-12-31) — Stockholders Equity: 2954012000.00
FRT balance_sheet (annual, 2022-12-31) — Tangible Book Value: 2794190000.00
FRT income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 34409970.00
FRT income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.21
FRT balance_sheet (annual, 2022-12-31) — Total Assets: 8233991000.00
FRT balance_sheet (annual, 2022-12-31) — Total Capitalization: 7283405000.00
FRT balance_sheet (annual, 2022-12-31) — Total Debt: 4474796000.00
FRT balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 3212385000.00
FRT income_statement (annual, 2022-12-31) — Total Expenses: 711827000.00
FRT balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 5021606000.00
FRT balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 7941329000.00
FRT balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 4712495000.00
FRT income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 526408000.00
FRT income_statement (annual, 2022-12-31) — Total Unusual Items: 163857000.00
FRT income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 163857000.00
FRT balance_sheet (annual, 2022-12-31) — Working Capital: -16449000.00
FRT income_statement (annual, 2023-12-31) — +Operating Expense: 372470000.00
FRT income_statement (annual, 2023-12-31) — +Total Revenue: 1132154000.00
FRT balance_sheet (annual, 2023-12-31) — Accounts Payable: 174714000.00
FRT balance_sheet (annual, 2023-12-31) — Accounts Receivable: 201733000.00
FRT balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 3959276000.00
FRT cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 0.00
FRT income_statement (annual, 2023-12-31) — Average Dilution Earnings: 0.00
FRT income_statement (annual, 2023-12-31) — Basic Average Shares: 81313000.00
FRT income_statement (annual, 2023-12-31) — Basic EPS: 2.80
FRT cash_flow (annual, 2023-12-31) — Beginning Cash Position: 96348000.00
FRT cash_flow (annual, 2023-12-31) — Capital Expenditure: -311120000.00
FRT cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -311120000.00
FRT balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 88540000.00
FRT balance_sheet (annual, 2023-12-31) — Capital Stock: 160655000.00
FRT balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 250825000.00
FRT balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 250825000.00
FRT cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -359194000.00
FRT cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -33849000.00
FRT cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -358325000.00